GRAHAM RICHARD A (SVP, Development) sold 0.7% of their position (2.48K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $25.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/16/2023ACC: 0001415889-23-015228
Officer· SVP, Development
Since Aug 2020
-2.48K
Net shares
Net seller
$25.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.48K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−2.48K
Price / share
$10.22
Trade value
$25.37K
% of position
0.7%
11/14/2023
349.32K→346.84K
Total
Net shares
−2.48K
Net value
-$25.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 11/14/2023 | S · Sale | −2.48K | $10.22 | $25.37K | 0.7% | 349.32K | 346.84K |
| Total | −2.48K | -$25.37K | ||||||
Derivative Transactions0
No derivative transactions reported